Doximity (NYSE:DOCS) Upgraded at Zacks Research

Doximity (NYSE:DOCS) was upgraded by research analysts at Zacks Research from a “hold” rating to a “strong-buy” rating in a report issued on Monday,Zacks.com reports.

DOCS has been the topic of a number of other reports. Wall Street Zen lowered shares of Doximity from a “buy” rating to a “hold” rating in a research note on Saturday, January 10th. Weiss Ratings restated a “hold (c+)” rating on shares of Doximity in a research note on Wednesday, December 24th. Wells Fargo & Company raised shares of Doximity from an “equal weight” rating to an “overweight” rating and set a $55.00 target price on the stock in a report on Tuesday, January 20th. Truist Financial upgraded shares of Doximity from a “hold” rating to a “strong-buy” rating in a research note on Thursday, January 8th. Finally, Royal Bank Of Canada raised shares of Doximity to a “moderate buy” rating in a report on Thursday, January 8th. Three equities research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $55.00.

Doximity Stock Up 0.6%

DOCS stock opened at $39.20 on Monday. Doximity has a 1 year low of $38.90 and a 1 year high of $85.21. The company has a market capitalization of $7.38 billion, a PE ratio of 31.11, a P/E/G ratio of 1.87 and a beta of 1.39.

About Doximity

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.